$AMBS’ wholly-owned subsidiary Elto Pharma, Inc.
Post# of 144499
(Total Views: 214)
Posted On: 06/19/2018 12:42:48 PM
$AMBS’ wholly-owned subsidiary Elto Pharma, Inc. has development rights to eltoprazine, a Phase 2b-ready small molecule indicated for Parkinson’s disease levodopa-induced dyskinesia, Alzheimer’s aggression and adult ADHD. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS’ wholly-owned subsidiary Cutanogen Corporation.
https://financialstrend.com/two-themes-could-...46629.html
https://financialstrend.com/two-themes-could-...46629.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼